STRATA CRITICAL MEDICAL, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $6.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-06-30 was $7.96M.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2026-03-31 was -$1.46M.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was -$1.42M, a 145.44% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was -$33.00K, a 111.04% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was -$4.28M, a 603.29% decline from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was $850.00K.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was -$2.13M.
- STRATA CRITICAL MEDICAL, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was -$24.23M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 7 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $7.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.51M 10-Q · filed 2026-08-04 | $5.09M derived: sum of 3 quarters · filed 2026-08-04 | $5.06M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | -$1.46M 10-Q · filed 2026-05-06 | -$2.88M derived: sum of 2 quarters · filed 2026-05-06 | -$2.91M derived: sum of 3 quarters · filed 2026-05-06 | -$2.98M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2025-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.45M derived: sum of 2 quarters · filed 2026-03-03 | -$1.53M derived: sum of 3 quarters · filed 2026-03-03 | -$4.28M 10-K · filed 2026-03-03 | |
| 2025-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$110.00K derived: sum of 2 quarters · filed 2025-11-10 | -$2.86M 10-Q · filed 2025-11-10 | $254.00K derived: sum of 4 quarters · filed 2026-03-03 | |
| 2025-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$2.83M 10-Q · filed 2025-08-05 | $287.00K derived: sum of 3 quarters · filed 2026-03-03 | $586.00K derived: sum of 4 quarters · filed 2026-03-03 | |
| 2025-03-31 | -$2.75M 10-Q · filed 2025-05-12 | $364.00K derived: sum of 2 quarters · filed 2026-03-03 | $663.00K derived: sum of 3 quarters · filed 2026-03-03 | $1.58M derived: sum of 4 quarters · filed 2026-03-03 | |
| 2024-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.42M derived: sum of 2 quarters · filed 2026-03-03 | $4.33M derived: sum of 3 quarters · filed 2026-03-03 | $850.00K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.21M derived: sum of 2 quarters · filed 2024-11-12 | -$2.27M 10-Q · filed 2024-11-12 | -$568.00K derived: sum of 4 quarters · filed 2025-03-13 | |
| 2024-06-30 | $913.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.56M 10-Q · filed 2024-08-08 | -$867.00K derived: sum of 3 quarters · filed 2025-03-13 | -$6.59M derived: sum of 4 quarters · filed 2025-03-13 | |
| 2024-03-31 | -$3.48M 10-Q · filed 2024-05-07 | -$1.78M derived: sum of 2 quarters · filed 2025-03-13 | -$7.50M derived: sum of 3 quarters · filed 2025-03-13 | -$5.04M derived: sum of 4 quarters · filed 2025-03-13 | |
| 2023-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$4.02M derived: sum of 2 quarters · filed 2025-03-13 | -$1.56M derived: sum of 3 quarters · filed 2025-03-13 | -$2.13M 10-K · filed 2025-03-13 | |
| 2023-09-30 | -$5.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$3.26M derived: sum of 2 quarters · filed 2023-11-08 | -$3.82M 10-Q · filed 2023-11-08 | -$5.81M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2023-06-30 | $2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.90M 10-Q · filed 2023-08-09 | -$88.00K derived: sum of 3 quarters · filed 2023-08-09 | -$513.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2023-03-31 | -$566.00K 10-Q · filed 2023-05-11 | -$2.55M derived: sum of 2 quarters · filed 2023-05-11 | -$2.98M derived: sum of 3 quarters · filed 2023-05-11 | -$22.24M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2022-12-31 | -$1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$2.41M derived: sum of 2 quarters · filed 2023-03-16 | -$21.68M derived: sum of 3 quarters · filed 2023-03-16 | -$24.23M 10-K · filed 2023-03-16 | |
| 2022-09-30 | -$425.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$19.69M derived: sum of 2 quarters · filed 2022-11-10 | -$22.24M 10-Q · filed 2022-11-10 | -$33.15M derived: sum of 4 quarters · filed 2023-01-10 | |
| 2022-06-30 | -$19.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$21.82M 10-Q · filed 2022-08-09 | -$32.73M derived: sum of 3 quarters · filed 2023-01-10 | ||
| 2022-03-31 | -$2.55M 10-Q · filed 2022-05-10 | -$13.46M derived: sum of 2 quarters · filed 2023-01-10 | |||
| 2021-12-31 | -$10.91M 8-K · filed 2023-01-10 | ||||
| 2021-09-30 | $18.33M 10-K · filed 2021-12-20 | ||||
| 2020-12-31 | $20.65M 10-K/A · filed 2021-05-07 | ||||
| 2019-12-31 | -$2.18M 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |